A share of Surgery Partners Inc. (NASDAQ:SGRY) closed at $24.91 per share on Thursday, down from $26.79 day before. While Surgery Partners Inc. has underperformed by -7.02%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SGRY fell by -45.65%, with highs and lows ranging from $63.87 to $24.05, whereas the simple moving average fell by -42.12% in the last 200 days.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
On June 15, 2022, BofA Securities Downgraded Surgery Partners Inc. (NASDAQ: SGRY) to Neutral. Barclays also rated SGRY shares as ‘Overweight’, setting a target price of $73 on the company’s shares in an initiating report dated November 30, 2021. JP Morgan initiated its ‘Neutral’ rating for SGRY, as published in its report on November 01, 2021. SVB Leerink’s report from October 18, 2021 suggests a price prediction of $50 for SGRY shares, giving the stock a ‘Outperform’ rating. Cowen also rated the stock as ‘Market Perform’.
Analysis of Surgery Partners Inc. (SGRY)
Further, the quarter-over-quarter increase in sales is 13.30%, showing a positive trend in the upcoming months.
Surgery Partners Inc.’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -2.80% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.40, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and SGRY is registering an average volume of 491.55K. On a monthly basis, the volatility of the stock is set at 6.32%, whereas on a weekly basis, it is put at 7.04%, with a loss of -14.95% over the past seven days. Furthermore, long-term investors anticipate a median target price of $56.56, showing growth from the present price of $24.91, which can serve as yet another indication of whether SGRY is worth investing in or should be passed over.
How Do You Analyze Surgery Partners Inc. Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.20%. This can enable you to see the extent to which executives own the company’s stock.
Are institutional investors increasing their holdings in SGRY shares?
The recent increase in stakes in SGRY appears to be a result of several institutional investors and hedge funds increasing their positions. Fidelity Management & Research Co’s position in SGRY has increased by 13.48% in the first quarter. The company now owns 12,222,567 shares of the stock, with a value of $336.49 million, following the purchase of 1,452,027 additional shares during the last quarter. ClearBridge Investments LLC made another increased to its shares in SGRY during the first quarter, upping its stake by 6.35%. During the last quarter, the company picked up 259,325 additional shares for a total stake of worth $119.53 million, bringing number of shares owned by the company to 4,341,837.
During the first quarter, The Vanguard Group, Inc. added a 61,573 position in SGRY. BlackRock Fund Advisors purchased an additional 0.26 million shares in the last quarter, increasing its holdings by 12.63%, now holding 2.29 million shares worth $62.91 million. At the end of the first quarter, T. Rowe Price Associates, Inc. decreased its SGRY holdings by -17.74% and now holds 2.19 million SGRY shares valued at $60.28 million with the lessened -0.47 million shares during the period.